03/03
Headlines
Gilead Sciences GILD NASDAQ:GILD

New Highs: China Biologic Products Inc (NASDAQ:CBPO), Centene Corp (NYSE:CNC), LifePoint Hospitals, Inc. (NASDAQ:LPNT), Universal Health Services, Inc. (NYSE:UHS)

Jayne Crisman02 mins

Jefferies Group assumed coverage on shares of China Biologic Products (NASDAQ:CBPO) in a report released on Thursday, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $52.00 price objective on the stock. China Biologic Products Inc (NASDAQ:CBPO) stock performance was 1.37% in last session and finished the day at $43.67. Traded volume was 59,338.00million…

Read More

Healthcare Losers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Imprimis Pharmaceuticals Inc (NASDAQ:IMMY), Evoke Pharma Inc (NASDAQ:EVOK), Cerulean Pharma Inc (NASDAQ:CERU)

Richard Atkins03 mins

On Friday, Inovio Pharmaceuticals Inc (NYSEMKT:INO) announced that its shareholders had approved 1-for-4 reverse stock split of company common stock. Company shares sank more than 5% in morning trading. The company said that the effective date of the reverse stock split would be disclosed at a future date after The company complies with “standard NYSE…

Read More

Financial Sector Volatile Stocks: Doral Financial Corp. (NYSE:DRL), CNinsure (NASDAQ:CISG), China Commercial Credit (NASDAQ:CCCR), ZipRealty (NASDAQ:ZIPR), RCS Capital Corp (NYSE:RCAP)

Jayne Crisman03 mins

S&P rates the Doral Financial Corp. (NYSE:DRL) holding company CC and has it on credit watch negative. Fitch’s gives issuer default ratings to Doral Financial Corp. (NYSE:DRL) of C, to First BanCorp of B-minus, to Popular Inc. of BB-minus, and to Santander Bancorp of BBB. Fitch gives Doral a negative outlook and the other three…

Read More

Notable Movers: ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), PTC Therapeutics, Inc. (NASDAQ:PTCT), Orexigen Therapeutics, Inc. (NASDAQ:OREX), CytRx Corporation (NASDAQ:CYTR), ZIOPHARM Oncology (NASDAQ:ZIOP)

Kristen Barton03 mins

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) presented results from a global, multi-center, open-label, comparator-controlled phase II study in patients undergoing total knee replacement surgery or total knee arthroplasty (TKA). Two doses of ISIS-FXIRx (200mg, 300mg) were compared to Sanofi’s Lovenox (enoxaparin). ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock performance was 11.26% in last session and finished the day at…

Read More

Hot Watch List: The Medicines Company (NASDAQ:MDCO), Omeros Corporation (NASDAQ:OMER), Northwest Biotherapeutics (NASDAQ:NWBO), Dehaier Medical Systems (NASDAQ:DHRM), Durata Therapeutics (NASDAQ:DRTX)

John Bellich03 mins

The Medicines Company (NASDAQ:MDCO) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported ($0.08) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.07) by $0.01. The company had revenue of $177.20 million for the quarter, compared to the consensus estimate of $175.60 million. During the same quarter…

Read More
Gilead Sciences GILD NASDAQ:GILD

Financial Sector Gainers: The St. Joe Company (NYSE:JOE), Ladenburg Thalmann Financial Services (NYSEMKT:LTS), Atlas Financial Holdings(NASDAQ:AFH), Citizens (NYSE:CIA), ZipRealty (NASDAQ:ZIPR)

Chris Lewis03 mins

The St. Joe Company (NYSE:JOE)’s shares rose 6% to 22.89 after Raymond James upgraded the real estate landholder and developer, saying its “huge” cash surplus is a good sign for the Fla. company’s plan to build the world’s largest retirement community. The St. Joe Company (NYSE:JOE) stock performance was 6.02% in last session and finished…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓